TNF and Crohn disease: Crohn’s disease medications used within the 2 years before vedolizumab or anti-TNFα index treatment initiation, respectively, included corticosteroids (58% vs 63%), aminosalicylates (29% vs 40%), and immunomodulatory agents (28% vs 53%) (Table 2).